NCT02721992View on ClinicalTrials.gov

Graves' Orbitopathy and Hypercholesterolemia

CompletedOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Graves' OphthalmopathyHypercholesterolemia
Interventions
OTHER

No intervention

No intervention

Trial Locations (1)

56124

Ospedale Cisanello-Endocrinology I and II, Pisa

All Listed Sponsors
lead

University of Pisa

OTHER

NCT02721992 - Graves' Orbitopathy and Hypercholesterolemia | Biotech Hunter | Biotech Hunter